KALA BIO, Inc. (KALA)
NASDAQ: KALA · Real-Time Price · USD
3.750
-0.090 (-2.34%)
At close: May 30, 2025, 4:00 PM
3.650
-0.100 (-2.67%)
After-hours: May 30, 2025, 5:32 PM EDT
KALA BIO Employees
KALA BIO had 38 employees as of December 31, 2024. The number of employees decreased by 5 or -11.63% compared to the previous year.
Employees
38
Change (1Y)
-5
Growth (1Y)
-11.63%
Revenue / Employee
n/a
Profits / Employee
-$938,184
Market Cap
24.00M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
KALA News
- 2 days ago - KALA BIO to Present at Jefferies Global Healthcare Conference - GlobeNewsWire
- 3 months ago - KALA BIO Announces Chief Executive Officer Transition - GlobeNewsWire
- 5 months ago - KALA BIO Announces $10,750,000 Private Placement - GlobeNewsWire
- 6 months ago - KALA BIO to Present at Piper Sandler 36th Annual Healthcare Conference - GlobeNewsWire
- 1 year ago - KALA BIO Reports First Quarter 2024 Financial Results and Provides Corporate Update - GlobeNewsWire
- 1 year ago - KALA BIO Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update - GlobeNewsWire
- 1 year ago - KALA BIO to Present at TD Cowen 44th Annual Healthcare Conference - GlobeNewsWire
- 1 year ago - KALA BIO Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire